Keywords: bioalliance, extends, loramyc, license, china, paris, france-based

BioAlliance extends Loramyc license to China

Article | 30 June 2008

Print This

Paris, France-based BioAlliance Pharma SA, which is focused on the treatment of opportunistic infections in cancer and HIV, has entered ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in